Regeneron Pharmaceuticals: Finding Stock Market Winners
Regeneron Pharmaceuticals' common shares will need to reach $1585 to achieve average annual stock market performance of 9.0% over the next 6 years. Regeneron Pharmaceuticals' stock price will need to reach $1866 by 2028 to achieve upper quartile performance. What is the market's view of Regeneron Pharmaceuticals' future operating performance as reflected in the current price of $945?
Our appraisal of potential stock price performance relative to its Peer Group and the overall stock market is based on three key drivers of value: Growth, Profitability, and Risk. Key Regeneron Pharmaceuticals characteristics: high financial strength, high expected growth, high stability, and average profitability. A big positive influence on Regeneron Pharmaceuticals' valuation is its superior Growth.
Regeneron Pharmaceuticals has a current Value Trend Rating of B (Positive). Stocks with high Value Trend Ratings are expected to outperform the general market while stocks with low Value Trend Ratings are expected to underperform.